StockData
Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc. (PVCT) stock

PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$0.05+0.00 (+0.39%)

Close on Oct 19, 2026Market cap $20.55MP/E –Yield –

Provectus Biopharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Provectus Biopharmaceuticals's price to book ratio was 5.4× on Apr 28, 2017, against 6.2× a year earlier. Over the last 5 years it ranged from 0.8× to 59.5×, with a median of 8.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Apr 28, 20175.4×+4.4
2016Dec 30, 20160.9×−2.3
2015Dec 31, 20153.3×−4.1
2014Dec 31, 20147.4×−31.3
2013Dec 31, 201338.7×+20.6
2012Dec 31, 201218.1×+10.8
2011Dec 30, 20117.3×–

More Provectus Biopharmaceuticals figures

See a number that looks wrong?